APA (7th ed.) Citation

SC, C., K, Z., N, A., P, M., Z, H., KR, B., . . . SK, S. (2025). A genome-wide in vivo CRISPR activation screen identifies BACE1 as a therapeutic vulnerability of lung cancer brain metastasis. Science translational medicine, 17(805), eadu2459. https://doi.org/10.1126/scitranslmed.adu2459

Chicago Style (17th ed.) Citation

SC, Chafe, et al. "A Genome-wide in Vivo CRISPR Activation Screen Identifies BACE1 as a Therapeutic Vulnerability of Lung Cancer Brain Metastasis." Science Translational Medicine 17, no. 805 (2025): eadu2459. https://doi.org/10.1126/scitranslmed.adu2459.

MLA (9th ed.) Citation

SC, Chafe, et al. "A Genome-wide in Vivo CRISPR Activation Screen Identifies BACE1 as a Therapeutic Vulnerability of Lung Cancer Brain Metastasis." Science Translational Medicine, vol. 17, no. 805, 2025, p. eadu2459, https://doi.org/10.1126/scitranslmed.adu2459.